
Course Overview
In This Video we will see inshort about contents of course
In this session we have seen about websites and their how to use during work in RA.
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is unique in bringing together the regulatory authorities and pharmaceutical industry to discuss scientific and technical aspects of pharmaceuticals and develop ICH guidelines.
Since its inception in 1990, ICH has gradually evolved, to respond to increasingly global developments in the pharmaceutical sector and these ICH guidelines are applied by a growing number of regulatory authorities. ICH's mission is to achieve greater harmonisation worldwide to ensure that safe, effective and high quality medicines are developed, and registered and maintained in the most resource efficient manner whilst meeting high standards
In this session we have seen about Basics consepts in ICH guidlines.
Literature survey required for both Researcher and RA professionals during there work.
In this session students will learn about online literatures. How to use websites and which information is available on online for Drug development of Pharmacetical products and Regulatory Compliance.
DMF stands for Drug Master File which contains confidential information related to the manufacturing, control or chemistry of the product.
US DMF filing is the provision made by the US FDA to maintain the confidentiality of the information in the DMF Filing. The Manufacturer of the Drug, excipient, or packaging material can directly submit the product related confidential information to the FDA without disclosing the information to their customer. However, the manufacturer may have to disclose parts of the DMF such as product specifications and general information to their customer, since such information is mandatory for product development and quality control related activities.
Facts about FDA DMF
DMF filing is not mandatory
DMF filing is the provision to submit the information directly to FDA without disclosing the information to your customer.
DMFs are neither approved nor disapproved. FDA reviews the DMF against drug applications in which those DMFs are referred.
FDA DMF number does not constitute FDA approval
Drug Master File holders must submit an amendment if there are any changes in the DMF and submit a report annually.
FDAbasics offer services for DMF filing services including DMF amendments and annual reports.
Students learned about Difference between Drug Master File and Various Application.
Students learned about submission of DMF. Also closing of DMF
Module 1 of the CTD describes the administrative information and prescribing information (for example, the application form, the proposed product information and labelling)
Advantages of the eCTD structure:
Reviewers are already familiar with the content and document standards
Local affiliates can review updates in real-time
FDA reviewers can review faster and more efficiently, shortening time to approval
Handling, managing, and archiving trial and document-essential information is less time-consuming
Documents are easily accessible via search and tracking
The risk of missing or duplicated documents is minimized
Module 2 contains the CTD overviews and sum- maries. It starts with a general introduction to the. drug, including its pharmacological class, mode of. action, and proposed clinical use.
CTD Module 3 is the section of the common technical document (CTD) regulatory submissions format that contains all the required quality information and data corresponding to the registration of a pharmaceutical product.
CTD Module 3 is well defined containing both drug substance (active ingredient) and drug product sections, with each containing required presentations of drug technical information, processes and key parameters, and various justification supported by qualification and validation studies.
This data and these reports provide the detailed evidence that a drug’s characteristics are well defined and well controlled, such that one can assure that the next lot produced is essentially the same as the last lot. Drug manufacture control and reproducibility is the essential message that Module 3 must convey if Agency reviewers are to conclude that a new drug application merits approval.
Module 4 describes the format and organisation of the nonclinical (pharmaco-toxicological) data relevant to the application
Module 5 contains all of the clinical study report data needed to support the application and to
demonstrate that the generic drug product is bioequivalent to the RLD.
Guidance Documents for NDAs
Guidance documents represent the Agency's current thinking on a particular subject. These documents are prepared for FDA review staff and applicants/sponsors to provide guidelines to the processing, content, and evaluation/approval of applications and also to the design, production, manufacturing, and testing of regulated products. They also establish policies intended to achieve consistency in the Agency's regulatory approach and establish inspection and enforcement procedures. Because guidances are not regulations or laws, they are not enforceable, either through administrative actions or through the courts. An alternative approach may be used if such approach satisfies the requirements of the applicable statute, regulations, or both. For information on a specific guidance document, please contact the originating office.
Are you looking for Regulatory affairs Jobs in 2024 and want to make a career in Pharmaceutical Regulatory affairs?
Answer:
If you are looking for Pharma Regulatory affairs course to start career as Regulatory Professional without paying huge amount or money then you are on right platform with best pilot.
This updated course is for starting career and growing in existing profession as in Regulatory affairs with certificate of completion.
Complete the course as per your free time as life time access is available.
Course Details:
The Pharmaceutical industry discovers, develops, produces, and markets drugs or pharmaceutical drugs for use as medications to be administered to patients, with the aim to cure them, vaccinate them, or alleviate the symptoms. Pharmaceutical companies may deal in generic or brand medications and medical devices
Regulatory Affairs plays a crucial role in the pharmaceutical industry and is involved in all stages of drug development and also after drug approval and marketing. ...
Pharmaceutical companies use all the data accumulated during discovery and development stages in order to register the drug and thus market the drug.
So, this online course helps Pharmacy Students and Professionals to build their knowledge and skills towards career in Regulatory Affairs.
Regulatory course prepares students to be skilled in the field of global regulatory affairs, and enables existing regulatory affairs professionals to refine and update their knowledge of global regulatory affairs statutes and practices.
Prepare to play a pivotal role in managing the regulatory activities necessary to bring drugs and medical products to market.
Learnings from this course:
Global regulatory frameworks (FDA, EMA, CDSCO, MHRA, TGA, and more)
Drug approval pathways (IND, NDA, ANDA, BLA)
CTD & eCTD dossier preparation
Clinical trial regulations & GCP
Why to choose this course:
Designed by industry experts with hands-on regulatory experience
Up-to-date content based on current global standards
Boost your job-readiness in pharma, biotech, and CRO sectors
Learn how to work across global markets with confidence
Certificate of Completion to enhance your professional profile
Contents of this course :-
A. Basics of Regulatory affairs
1. Basic Regulatory Introduction
2. Career and opportunities in RA
3. Objectives in RA Profession
4. Websites and Usage
5. Intoduction to ICH Guidelines
6. Basic general information about DMF (Drug Master File)
7. DMF preparation and submission
B. CTD & eCTD
8. Module 1
9. Module 2
10. Module 3
11. Module 4
12. Module 5
13. eCTD software demo and eValidation
C. Types of Application
14. IND (Investigational New Drug Application)
15. NDA (New Drug Application)
16. ANDA (Abbreviated New Drug Application)
D. Registration and Submission
17. Introduction to ESG Gateway
18. Overview of Registration Process
19. FDA ESG web interface and electronic submission
# Complimentary Quizes (Question & Answer)
Eligibility Requirements
Education and experience:
A minimum of a baccalaureate or equivalent Lifescience subjects OR
Bachelors of Pharmacy, Masters of Pharmacy, Ph.D In Pharmacy, Industrial Professional
A master’s degree of regulatory or regulatory-related experience; OR
A doctorate degree (e.g., medical, dental degree, PharmD, PhD, ScD, JD) and at least one year regulatory or regulatory-related experience
No Prerequisite required only need Curiosity over new learnings
Regulatory Certification Benefits for Professionals
Anyone who works in the life science arena should consider the RAC program as an educational supplement to one’s current work environment. As identified in the RAC Certification, earning a RAC is useful in a variety of professional settings, within regulatory agencies, government and inter-governmental bodies, industry, consultancies, professional organizations, healthcare facilities, research institutions and educational institutions around the world.
Confidence is a true benefit from adding the RAC to your signature line, as a regulatory professional.
Course is designed to cover all aspects of healthcare product regulations, compliance and standards, giving a global perspective on regulatory affairs. There are practice exams available online to help prepare.
Certification by a Regulatory Professional platform not only gives you confidence in forming your regulatory advisements but also inspires confidence in those working with you or for whom you work. There is recognition that, by pursuing a regulatory certification, you have studied the regulations in your particular regulatory product area and are well versed in these regulations as well as in other product categories.
The ability to pass an exam written by your peers in your specific area of regulatory responsibility affirms that regulatory professionals have a clear understanding of the core components within their specialty area.
In this Advanced RA course the Detailed Practical and Theoretical aspects of Regulatory affairs can be learned in this course.
Like :-
Basics of Regulatory affairs
ICH, DMF, ASMF, CTD, eCTD, CTD structure, 1-5 Modules of CTD.
Basic Demonstration of eCTD software & eValidator (Lorenz Docubridge) 21CFR complied.
Drug Product Development, Documents Required for filling.
Preperation & Submission of CTD, eCTD, DMF, Filling of Applications (IND, NDA, ANDA, BLA).
Other miscellaneous Aspects in RA.
Stringent GMPs are being followed for blood and its derivative as well as controlled manufacturing for Traditional Herbal Medicines, Cosmetics, Food and Dietary products which was otherwise differently a century before. Each regulatory system had faced certain circumstances which led to current well-defined controlled regulatory framework.
This course contains Commonly Asked Questions and Answers for interview that will help you while preparing for DRA interviews.
Last but not the least, this course also contains a bonus software demo entitled "General Demonstration and eValidation " which will help you to shape your career in which the points that must be taken into consideration while Preparing and submission of Dossier are covered.
In this course, more than 42 informative videos are included and are designed in an easily digestible format and going to take you through step by step approach to understand Drug Regulatory Affairs and relevant activities. This course will help you to develop the ability to conduct regulatory intelligence and develop a regulatory strategic plan.
I believe "Quality improvement is a continuous and lifetime process". Upon completion of this course, you will be a whole different professional with improved DRA skills and knowledge which will help you to garner more respect from your team members, managers, clients, or anyone with whom you are communicating/interacting.